Futura Medical plc (LON:FUM – Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 37.13 ($0.49) and traded as low as GBX 35.70 ($0.47). Futura Medical shares last traded at GBX 35.90 ($0.47), with a volume of 165,192 shares changing hands.
Futura Medical Stock Down 0.3 %
The company has a market cap of £108.37 million, a P/E ratio of -3,590.00 and a beta of 1.25. The company’s 50-day moving average is GBX 35.23 and its two-hundred day moving average is GBX 37.13.
Insiders Place Their Bets
In other Futura Medical news, insider James Henry Barder sold 250,000 shares of the stock in a transaction dated Friday, September 13th. The shares were sold at an average price of GBX 41 ($0.54), for a total transaction of £102,500 ($135,402.91). Company insiders own 34.14% of the company’s stock.
Futura Medical Company Profile
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
See Also
- Five stocks we like better than Futura Medical
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- EV Stocks and How to Profit from Them
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.